Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
GLP-1 Agonists: Optimizing Therapy Across Clinical Scenarios (1.5 hours) CE/CME Course #: 25-396 Review clinical guidance on optimizing use of GLP-1 receptor agonists (RAs) for managing type 2 diabetes and weight loss, as well as their role in cardiovascular and kidney diseases
Looking for Market Leaders Only two companies, Eli Lilly and Novo Nordisk, have sizable GLP-1s available today, and we expect them to dominate the market over the intermediate term
If your progress has stalled despite consistent dosing, the peptide may have degraded
Efficacy and safety of HIMABERB Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial
Because alcohol is known to challenge these levels, navigating the science helps you optimize your health choices
US$ 27.22
US$ 27.62
US$ 20.71
US$ 23.00
US$ 24.49
US$ 22.29
US$ 21.14
US$ 25.50
US$ 24.07
US$ 29.00
US$ 29.08
US$ 22.58
US$ 24.49
US$ 26.46
US$ 27.55
